Swiss National Bank
FPRX

Swiss National Bank’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Swiss National Bank’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-56,200
Closed -$218K – 2559
2019
Q3 		$218K Hold
56,200
– – ﹤0.01% 2491
2019
Q2 		$339K Sell
56,200
-6,700
-11% -$64.1K ﹤0.01% 2501
2019
Q1 		$843K Hold
62,900
– – ﹤0.01% 2161
2018
Q4 		$585K Buy
62,900
+3,500
+6% +$41.6K ﹤0.01% 2292
2018
Q3 		$827K Hold
59,400
– – ﹤0.01% 2248
2018
Q2 		$939K Hold
59,400
– – ﹤0.01% 2204
2018
Q1 		$1.02M Buy
59,400
+11,200
+23% +$218K ﹤0.01% 2063
2017
Q4 		$1.06M Hold
48,200
– – ﹤0.01% 2062
2017
Q3 		$1.97M Hold
48,200
– – ﹤0.01% 1627
2017
Q2 		$1.45M Buy
48,200
+6,300
+15% +$197K ﹤0.01% 1792
2017
Q1 		$1.51M Hold
41,900
– – ﹤0.01% 1756
2016
Q4 		$2.1M Buy
41,900
+2,000
+5% +$105K ﹤0.01% 1515
2016
Q3 		$2.09M Sell
39,900
-1,100
-3% -$52.5K ﹤0.01% 1473
2016
Q2 		$1.7M Buy
41,000
+6,400
+18% +$278K ﹤0.01% 1624
2016
Q1 		$1.36M Buy
34,600
+8,100
+31% +$278K ﹤0.01% 1709
2015
Q4 		$1.1M Hold
26,500
– – ﹤0.01% 1757
2015
Q3 		$408K Buy
26,500
+3,300
+14% +$70.9K ﹤0.01% 2283
2015
Q2 		$576K Buy
+23,200
New +$517K ﹤0.01% 2159

Other funds holding FPRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Swiss National Bank's FPRX Position: Q4 2019 in Review

Swiss National Bank sold out of Five Prime Therapeutics, Inc. (FPRX) in Q4 2019, closing a stake of 56,200 shares — an estimated $218K sold.

Swiss National Bank first reported a position in FPRX in Q2 2015 and held it in 18 quarters. The position peaked at $2.1M in Q4 2016. 94 funds tracked by Wall St. Rank hold FPRX as of Q4 2019.

  • Swiss National Bank reported no remaining Five Prime Therapeutics, Inc. position as of Q4 2019 after selling out during the quarter.
  • Swiss National Bank sold 56,200 Five Prime Therapeutics, Inc. shares in Q4 2019, an estimated $218K.
  • Swiss National Bank first reported a position in Five Prime Therapeutics, Inc. in Q2 2015 and held it in 18 quarters.
  • Swiss National Bank's Five Prime Therapeutics, Inc. position peaked at $2.1M in Q4 2016.
  • 94 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2019.

Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.